|Year : 2015 | Volume
| Issue : 1 | Page : 61-63
Progressive hemifacial atrophy with ciliary body atrophy and ocular hypotony
T Ashwini Kini1, VS Prakash1, Suresh Puthalath1, PL Bhandari2
1 Department of Ophthalmology, Comtrust Super Speciality Eye Hospital, Calicut, Kerala, India
2 Department of Plastic Surgery, Govt. Medical College, Calicut, Kerala, India
|Date of Submission||26-Jan-2014|
|Date of Acceptance||20-Jan-2015|
|Date of Web Publication||16-Feb-2015|
T Ashwini Kini
Chilimbi Hilldale Road, P.O. Ashok Nagar, Ladyhill, Mangalore 575 006, Karnataka
Source of Support: None, Conflict of Interest: None
Progressive hemifacial atrophy (PHA) is a disease of unknown etiology affecting one-half of the face. Ocular involvement is uncommon. Atrophy of iris is rare, with only a few cases of partial atrophy being reported in the literature. We report a case of total atrophy of iris and ciliary body with associated ocular hypotony in a 16-year-old girl with PHA. We believe this is the first reported case of complete atrophy of iris and ciliary body in PHA. Ocular hypotony in PHA was thought to be due to intra-ocular inflammation. However in our case it appears to be secondary to severe atrophy of the ciliary body.
Keywords: Ciliary body atrophy, iris atrophy, ocular hypotony, progressive hemifacial atrophy
|How to cite this article:|
Kini T A, Prakash V S, Puthalath S, Bhandari P L. Progressive hemifacial atrophy with ciliary body atrophy and ocular hypotony. Indian J Ophthalmol 2015;63:61-3
|How to cite this URL:|
Kini T A, Prakash V S, Puthalath S, Bhandari P L. Progressive hemifacial atrophy with ciliary body atrophy and ocular hypotony. Indian J Ophthalmol [serial online] 2015 [cited 2018 Dec 18];63:61-3. Available from: http://www.ijo.in/text.asp?2015/63/1/61/151474
Parry-Romberg syndrome More Details or progressive hemifacial atrophy (PHA) affects the skin, soft tissue and skeletal structures of the face. Ocular involvement occurs in 10-35%, ranging from uveitis to enophthalmos. , Ocular hypotony in PHA has been attributed to intra-ocular inflammation. Atrophy of iris in PHA is very rare, with only a few cases of partial iris atrophy being reported previously. We report a case of PHA with complete atrophy of iris and ciliary body. We hypothesize that the accompanying severe ocular hypotony may be secondary to atrophy of the ciliary body.
| Case Report|| |
A 16-year-old girl presented with painless progressive diminution of vision in right eye since 2 years, associated with glare. Left eye was asymptomatic. She noticed asymmetry of her face at 13 years of age and was diagnosed with PHA. The asymmetry was progressive, and she received fat grafting on the right side of her face. There were no systemic manifestations like seizures, migraine, intellectual deterioration, trigeminal neuralgia or neuropsychiatric disturbances.
General physical examination showed atrophy of the right half of the face involving subcutaneous tissue, muscle and bone [Figure 1]. There was no neurologic deficit or oral involvement. Visual acuity was 20/60 in right eye and 20/20 in left eye. Best-corrected visual acuity was 20/20 with + 2.25 cylinder at 90° in right eye.
Right eye had enophthalmos and severe hypotony with intraocular pressure of 4 mm of Hg by Goldmann's applanation tonometer. Intra-ocular pressure of her left eye was 16 mm of Hg. Slit lamp examination of right eye revealed marked iris atrophy amounting to aniridia. The pupil was fully dilated and nonreactive to light and accommodation [Figure 2]. Lens showed partial subluxation inferiorly. Fundus examination showed hypotonic maculopathy with internal limiting membrane folds radiating across the macula [Figure 3]. Gonioscopy showed open angles with broad ciliary body band. Ultrasound biomicroscopy revealed atrophic iris and ciliary body [Figure 4]. Lids, adnexa and ocular motility were normal. There was no evidence of iridocyclitis or retinal vasculitis in this patient.
|Figure 2: Slit lamp diffuse illumination showing near total iris atrophy with dilated pupil|
Click here to view
|Figure 4: Ultrasound biomicroscopy of both eyes showing iris with ciliary body atrophy on the right side|
Click here to view
At 6 months follow-up, the intra-ocular pressure in her right eye has further reduced to 2 mm of Hg. However, best-corrected visual acuity remains 6/6 with the same correction. Fundus and ultrasound bio-microscopy findings remained the same.
| Discussion|| |
The clinical features of PHA were initially observed by Caleb Hillier Parry in 1825 and subsequently described by Moritz Heinrich Romberg in 1846. , Although the exact etiology is unknown it is believed to be related to localized facial scleroderma.  The pathological process consists of chronic lymphocytic infiltration around neurovascular bundles. PHA has a slight female preponderance with age of onset around 5-15 years. , It is usually unilateral. There are progressive atrophy and deformation of one side of the face, resulting in unilateral facial atrophy, deviation of mouth and nose toward affected side.  PHA has been linked with various neurologic, ophthalmic, cardiac, rheumatologic, infectious, endocrine, maxillofacial and orthodontic manifestations.
Involvement of the eye is uncommon and reported to be in the range of 10-35%. Various ophthalmic associations so far reported are listed in [Table 1]. , A few cases of partial iris atrophy have been reported in the literature. Preechawat et al. reported a case of partial iris atrophy with sluggishly reacting 3 mm-pupil.  Two cases of partial iris atrophy with poor light reflex were reported by Miller and Spencer.  Dawczynski et al. reported a patient with pupillary abnormalities with enophthalmos.  However, the condition of the ciliary body was not mentioned. All these cases reported partial atrophy of the iris.  In our case, there was total atrophy of iris and ciliary body and with ocular hypotonia. Ocular hypotony has been attributed as being secondary to intraocular inflammation. But in our case we believe ocular hypotony occurred secondary to ciliary body atrophy. To our best knowledge, such a combination of features has not been described in the literature before. Atrophy of iris and ciliary body may be a part of generalized facial atrophy.
|Table 1: Various ocular manifestations associated with Parry Romberg syndrome[3,6] |
Click here to view
No specific treatment has been mentioned for ocular involvement PHA. Hypotony has been managed by silicone oil injections in some cases. Antiinflammatory drugs might be given in patients with active inflammatory disease. Facial and oculoplastic surgery may be done for cosmetic purposes. 
| References|| |
Miller MT, Sloane H, Goldberg MF, Grisolano J, Frenkel M, Mafee MF. Progressive hemifacial atrophy (Parry-Romberg disease). J Pediatr Ophthalmol Strabismus 1987;24:27-36.
Muchnick RS, Aston SJ, Rees TD. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmol 1979;88:889-97.
Jurkiewicz MJ, Nahai F. The use of free revascularized grafts in the amelioration of hemifacial atrophy. Plast Reconstr Surg 1985;76:44-55.
Cory RC, Clayman DA, Faillace WJ, McKee SW, Gama CH. Clinical and radiologic findings in progressive facial hemiatrophy (Parry-Romberg syndrome). AJNR Am J Neuroradiol 1997;18:751-7.
El-Kehdy J, Abbas O, Rubeiz N. A review of Parry-Romberg syndrome. J Am Acad Dermatol 2012;67:769-84.
Stone J. Parry-Romberg syndrome: A global survey of 205 patients using the Internet. Neurology 2003;61:674-6.
Pensler JM, Murphy GF, Mulliken JB. Clinical and ultrastructural studies of Romberg's hemifacial atrophy. Plast Reconstr Surg 1990;85:669-74.
Preechawat P, Phuchantuk P, Leelawongs K. Ocular abnormalities in Parry-Romberg syndrome. Thai J Ophthalmol 2011;25:43-8.
Miller MT, Spencer MA. Progressive hemifacial atrophy. A natural history study. Trans Am Ophthalmol Soc 1995;93:203-15.
Dawczynski J, Thorwarth M, Koenigsdoerffer E, Schultze-Mosgau S. Interdisciplinary treatment and ophthalmological findings in Parry-Romberg syndrome. J Craniofac Surg 2006;17:1175-6.
Alencar JC, Andrade SH, Pessoa SG, Dias IS. Autologous fat transplantation for the treatment of progressive hemifacial atrophy (Parry-Romberg syndrome: Case report and review of medical literatute). An Bras Dermatol 2011;86:S85-8.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]